Analysis of Inventory
Inventory Disclosure
AbbVie Inc., balance sheet: inventory
US$ in millions
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The inventory data over the five-year period reveals distinct trends across different categories of inventory held by the company.
- Finished Goods
- The value of finished goods demonstrates variability rather than a consistent rise or fall. Starting at 1,318 million US dollars in 2020, it declined significantly to 932 million in 2021, followed by a recovery in 2022 to 1,162 million. A slight increase was observed in 2023, reaching 1,356 million, before a decrease to 1,173 million in 2024. This fluctuation may indicate shifts in production output, sales performance, or inventory management strategies over the years.
- Work-in-Process
- The work-in-process inventory exhibits a generally increasing trend throughout the period. Beginning at 1,201 million US dollars in 2020, it remained stable through 2021 (1,193 million), then increased significantly to 1,417 million in 2022, followed by further growth in 2023 and 2024 to 1,643 million and 1,951 million, respectively. This consistent rise suggests expanding ongoing production activities or longer production cycles that lead to higher capital tied up in unfinished goods.
- Raw Materials
- Raw materials inventory increased from 791 million US dollars in 2020 to 1,003 million in 2021, remaining relatively stable in 2022 at 1,000 million. It saw another increase to 1,100 million in 2023 before a slight decline to 1,057 million in 2024. This pattern implies somewhat steady procurement levels with moderate fluctuations, possibly reflecting efforts to maintain supply chain readiness without excessively overstocking.
- Total Inventories
- The total inventories, comprising finished goods, work-in-process, and raw materials, indicate a clear upward trajectory over the five-year span. From 3,310 million US dollars in 2020, inventories slightly declined in 2021 to 3,128 million but then increased substantially each subsequent year, reaching 3,579 million in 2022, 4,099 million in 2023, and 4,181 million in 2024. This upward trend underscores an overall increase in inventory holdings, which may reflect growth in business scale, higher demand anticipation, or less efficient inventory turnover.